Medico Remedies Ltd - 540937 - Outcome Of Board Meeting Held Today
Please find attached Unaudited Financial Results for the quarter and half year ended 30th September, 2023 approved at Board meeting held today.09-11-2023
09-11-2023
Medico Remedies Ltd - 540937 - Board Meeting Outcome for Outcome Of Board Meeting Held Today
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors at their Meeting held today i.e. 9" November, 2023 has, inter alia considered and approved the Unaudited Financial Results for the quarter and half year ended 30" September, 2023 alongwith Auditors' Limited Review Report thereon. We wish to inform you that the Board Meeting commenced today at 3.00 P.M and concluded at 5.10 P.M09-11-2023
Medico Remedies Ltd - 540937 - Submission Of Report Under Regulation 10(7) Of Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 ('Takeover Regulation')
With respect to the captioned subject, we have received the below attached documents from Mr. Haresh Kapurlal Mehta as required under Regulation 10(7) of SEBI (SAST) Regulations, 2011. Kindly note that the disclosures under Regulation 10(5), 10(6) and 29(1) & 29(2) of the SEBI (SAST) Regulations, 2011 have already been submitted.07-11-2023
Medico Remedies Ltd - 540937 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta03-11-2023
Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta03-11-2023
Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta03-11-2023
Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta HUF03-11-2023
Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations, 2015, please find attached disclosure submitted by Haresh Kapurlal Mehta HUF, Promoter of the Company02-11-2023
Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations, 2015, please find attached disclosure submitted by Mr. Haresh Kapurlal Mehta, Promoter wrt acquisition of 98,72,000 equity shares of the company.02-11-2023
Medico Remedies Ltd - 540937 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
Please find attached Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 submitted by Haresh Kapurlal Mehta HUF, Promoter of the Company02-11-2023